24/7 Wall St. » Search Results » EZCH

Top Active Trader Alert Stocks (AKAM, CSCO, SQNM, EZCH)

Douglas A. McIntyre — Thu, 10 Feb 2011 13:55:17 +0000

Active traders and day traders have many stocks to choose from this Thursday morning. We are tracking news and moves in shares of Akamai Technologies, Inc. (NASDAQ: AKAM), Cisco Systems, Inc. (NASDAQ: CSCO), Sequenom, Inc. (NASDAQ: SQNM), and EZchip Semiconductor.

Akamai Technologies, Inc. (NASDAQ: AKAM) is down nearly 12% premarket to $42.30, relative to a 52-week range of $24.64-$54-65. The company reported positive earnings which were nevertheless below analyst expectations.

Cisco Systems, Inc. (NASDAQ: CSCO) is down more percent on very high volume to $19.69, relative to a 52-week range of $19.00-$27.47. Cisco reported atrocious second quarter earnings after market close yesterday.

Sequenom, Inc. (NASDAQ: SQNM) is up nearly 13% on heavy volume, relative to a 52-week range of $4.10-$8.65.

EZchip Semiconductor (NASDAQ: EZCH) is down 13% premarket to $27.80, relative to a 52-week range of $13.13-$33.48.

Filed under: Active Trader, Pre-Market Activity, Trading Alert Tagged: AKAM, CSCO, EZCH, SQNM

Top Day Trader Alerts (FSLR, EZCH, YONG, C, SQNM)

Douglas A. McIntyre — Thu, 17 Dec 2009 14:03:47 +0000

These are this Thursday’s top day trader alerts and active trader alerts. We have links to more details and analysis over at VSInvestor.com for each stock:

First Solar Inc. (NASDAQ: FSLR) is up about 2% on guidance but off last night’s highs..

EZchip Semiconductor Ltd. (NASDAQ: EZCH) is down another 3% after yesterday’s drop on the secondary offering.

Yongye International, Inc. (NASDAQ: YONG) is down over 9% on a secondary offering.

Citigroup Inc. (NYSE: C) is nuts today and down at $3.15, right where the secondary priced. Look for 1 billion shares by the open.

Sequenom Inc. (NASDAQ: SQNM) is down over 8% on allegations it fudged test results.

You can sign up for our free daily email to hear more news on key analyst calls, top day trader alerts, mergers and acquisitions, Buffett and other investment gurus, IPOs, secondary offerings, private equity, and more.

JON C. OGG

Posted in Active Trader, Pre-Market Activity, Trading Alert Tagged: C, EZCH, FSLR, SQNM, YONG

Top Day Trader Alerts (EZCH, FGXI, ACHN, GIGM, SCHW)

Douglas A. McIntyre — Wed, 16 Dec 2009 13:58:11 +0000

This morning’s top day trader and active trader alerts are in some less common names than what we normally see. These also have links through to VSInvestor.com with more detailed data and analysis:

EZchip Semiconductor Ltd. (NASDAQ: EZCH) is down 5% on a secondary offering.

FGX International Holdings Limited (NASDAQ: FGXI) is up almost 9% on a low-premium buyout.

Achillion Pharmaceuticals, Inc. (Nasdaq: ACHN) looks like the biggest gainer this morning as traders chase small cap and low-priced biotechs.

GigaMedia Ltd. (NASDAQ: GIGM) is up 10% on a gaming pact in Europe.

Charles Schwab (NASDAQ: SCHW) is up 2% on the Deutesche Bank upgrade.

JON C. OGG

Posted in Active Trader, Pre-Market Activity, Trading Alert Tagged: ACHN, EZCH, FGXI, GIGM, SCHW

Body Central Secondary, Discount Outweighs Dilution (BODY)

Jon C. Ogg — Fri, 11 Feb 2011 13:01:32 +0000

Body Central Corp. (NASDAQ: BODY) has a secondary offering which priced at a healthy discount for those who are getting shares. It should have come at a discount since almost the entire sale is from insiders of the company. We originally had up to 5 million shares indicated in the sale and the actual offering came to 4,959,795 shares of common stock. Body Central is a retailer of young women’s apparel and accessories.

The price went off at $16.50 per share versus the close of $16.87 yesterday and versus the price of $17.98 from before the secondary offering paperwork was filed after the close on January 27, 2011. Keep in mind that it was January 10, 2011 after the close that Body Central raised its earnings and revenue guidance and shares overnight went from $15.11 to $19.24 before peaking a couple days later at $21.30.

This company just came public in October of 2010 in a 5 million share offering at $13.00 per share. The offering priced under expectations, but the shares actually traded higher.

Piper Jaffray and Jefferies & Co. were the lead managers of the original IPO and they are both the lead managers of today’s offering.

Since its IPO, shares have traded in a range of $11.98 to $21.30. Normally we’d say that this offering is simply enriching the original investor groups rather than helping the company. It seems that the discounting was enough to entice buyers because the pre-market indications have shares up around $17.20 in the pre-market trading.

JON C. OGG

Filed under: Apparel, IPOs, IPOs & Secondaries, Retail Tagged: BODY

Top 2010 Stock Picks from… Everyone (AAPL, GE, CMCSA, MRVL, BIDU, DRYS, POT, LVLT, C, CVX, HPQ, KBH)

Douglas A. McIntyre — Fri, 01 Jan 2010 11:59:56 +0000

2009 is over, for better or worse. Now it is time to look ahead. We wanted to look for the best top stock picks for 2010 from our partners and from key financial websites. We compiled all of these 2010 stock picks into grouped lists with links directly to each, but there was one standout issue here: Apple Inc. (NASDAQ: AAPL) and General Electric Co. (NYSE: GE) were hardly picked for 2010. Some of the more common and widely held names that came up as common 2010 stock picks were Comcast Corporation (NASDAQ: CMCSA), Marvell Technology Group Ltd. (NASDAQ: MRVL), Baidu, Inc. (NASDAQ: BIDU), DryShips, Inc. (NASDAQ: DRYS), Potash Corp. of Saskatchewan (NYSE: POT), Level 3 Communications Inc. (NASDAQ: LVLT), Citigroup Inc. (NYSE: C), Chevron Corp. (NYSE: CVX), Hewlett-Packard Company (NYSE: HPQ), and KB Home (NYSE: KBH). There are literally dozens of other stock picks in 2010′s top stock picks.

We have links to the top 2010 stock picks from InvestorPlace.com, TheStreet.com, DailyFinance.com, BloggingStocks.com, MarketWatch, Fortune, Smart Money, MorningStar, and even from our own picks for 2010 and some potential 10-bagger Biotech stocks at BioHealthInvestor.com. In this we have only provided the stock names, and price targets, expectations, and every other detail is in the link at each grouping.

BioHealthInvestor.com “Potential 10-Bagger Biotechs for 2010″

InvestorPlace.com “How to Make Money in 2010″

Sourcefire, Inc. (NASDAQ: FIRE)
Marvell Technology Group (NASDAQ: MRVL)
Hi-Tech Pharmacal (NASDAQ: HITK)
Baidu Inc. (NASDAQ: BIDU)
Dril-Quip, Inc. (NYSE: DRQ)

InvestorPlace.com “5 Great Retail Stocks for 2010″

Abercrombie & Fitch Co. (NYSE: ANF)
Chico’s FAS Inc. (NYSE: CHS)
Guess? Inc. (NYSE: GES)
Jos. A. Bank Clothiers (NASDAQ: JOSB)
Nordstrom Inc. (NYSE: JWN)

InvestorPlace.com “Trends from China for 2010″

Duoyuan Global Water Inc. (NYSE: DGW)
Xinyuan Real Estate (NYSE: XIN)
Baidu, Inc. (NASDAQ: BIDU)
Ctrip.com International Ltd. (NASDAQ: CTRP)

InvestorPlace.com “Top 5 Stocks for January” by Louis Navellier

Amazon.com Inc. (NASDAQ: AMZN)
AmBev (NYSE: ABV)
Baidu, Inc. (NASDAQ: BIDU)
Cognizant Technology (NASDAQ: CTSH)
Marvell Technology Group (NASDAQ: MRVL)

TheStreet.Com “Top Tech Stocks for 2010″

Amazon.com Inc. (NASDAQ: AMZN)
Comcast Corp. (NASDAQ: CMCSA)
Microsoft Corporation (NASDAQ: MSFT)
Red Hat Inc. (NYSE: RHT)
Research-in-Motion Ltd. (NASDAQ: RIMM)
VMware, Inc. (NYSE: VMW)

TheStreet.com also has two dividend picks for 2010:

Kimberly-Clark (NYSE: KMB)
CenturyTel (NYSE: CTL)

The Street.com “5 Shippers to Watch in 2010″

DryShips, Inc. (NASDAQ: DRYS)
Diana Shipping Inc. (NYSE: DSX)
Genco Shipping & Trading Ltd. (NYSE: GNK)
Navios Maritime Holdings Inc. (NYSE: NM)

Ten stocks for 2010, by James Altucher of TheStreet.com on AOL’s Daily Finance

Assured Guaranty (NYSE: AGO)
Wellcare Health Plans, Inc. (NYSE: WCG)
Potash Corp. of Saskatchewan (NYSE: POT)
Cash America International, Inc. (NYSE: CSH)
Becton Dickison & Co. (NYSE: BDX)
Hillenbrand, Inc. (NYSE: HI)
Telecom Corp. of New Zealand NYSE: (NZT)
STEC, Inc. (NASDAQ: STEC)
Alvarion Ltd. (NASDAQ: ALVR)
GlaxoSmithKline plc (NYSE: GSK)

MarketWatch.com “10 Turnarounds for 2010″ by Mark Hulbert:

Boston Scientific Corp. (NYSE: BSX)
The Brinks Co. (NYSE: BCO)
Citigroup Inc. (NYSE: C)
Eli Lilly & Co. (NYSE: LLY)
Integrated Device Technology (NASDAQ: IDTI)
KB Home (NYSE: KBH)
Level 3 Communications Inc. (NASDAQ: LVLT)
Molina Healthcare Inc. (NYSE: MOH)
The New York Times Company (NYSE: NYT)
Wendy’s/Arby’s Group (NYSE: WEN)

FORTUNE’s “Promising Companies for 2010″

Mastercard Inc. (NYSE: MA)
Amedisys Inc. (NASDAQ: AMED)
QUALCOMM Inc. (NASDAQ: QCOM)
PetroHawk Energy Corporation (NYSE: HK)
Baxter International (NYSE: BAX),
Quanta Services Inc. (NYSE: PWR)
Salesforce.com (NYSE: CRM)
American Tower Corp. (NYSE: AMT)
Vornado Realty Trust (NYSE: VNO)

Smart Money’s “Where to Invest in 2010″
The Recession Return picks:

GoldCorp. (NYSE: GG)
The Coca-Cola COmpany (NYSE: KO)
Procter & Gamble (NYSE: PG)
Abbott Laboratories (NYSE: ABT)

Plodding Along:

Strayer Education (NASDAQ: STRA)
Chevron Corp. (NYSE: CVX)
Hewlett-Packard (NYSE: HPQ)
Changyou.com Ltd. (NASDAQ: CYOU)

FAST TRACK PICKS:

Ingersoll-Rand (NYSE: IR)
Jos. A. Bank Clothiers (NASDAQ: JOSB)
BB&T Corp. (NYSE: BBT)
Kirby (NYSE: KEX)

MorningStar’s “10 Ultimate Stock-Pickers’ Stocks to Consider During 2010″:

Abbott Laboratories (NYSE: ABT)
Applied Materials Inc. (NASDAQ: AMAT)
Apollo Group (NASDAQ: APOL)
ExxonMobil Corp. (NYSE: XOM)
Genzyme Corp. (NASDAQ: GENZ)
ITT Education Services (NYSE: ESI)
Lowe’s Companies Inc. (NYSE: LOW)
Monsanto Co. (NYSE: MON)
Stryker Corp. (NYSE: SYK)
Thermo Fisher Scientific, Inc. (NYSE: TMO)

BloggingStocks.com has a best of 2010 picks list with some stocks as follows, from various writers, and these are a few picks from the first page:

American Superconductor Corp. (NASDAQ: AMSC)
China Advanced Construction Systems (NASDAQ: CADC)
Dollar Tree (NASDAQ: DLTR)
Kinder Morgan Energy Partners (NYSE: KMP)
EZchip Semiconductor (NASDAQ: EZCH)
National CineMedia (NASDAQ: NCMI)

247WallSt.com also created several important stock pick lists of its own for 2010:

Berkshire Hathaway Inc. (NYSE: BRK-A) holdings with the most upside from analyst target prices for 2010.
Will oil hit $100 in 2010?
Top 10 Brands for 2010
Will gold stay dead into 2010, or was the end of 2009 just the pause?
Here are 12 major M&A candidates for 2010, a dream list in a sense.
And then on the pessimistic side…. 10 brands that will disappear in 2010.

I would like to personally invite you to join in with the thousands of readers on our free daily email distribution list to hear about major market pundit stock picks, analyst upgrades and downgrades, day trader and active trader alerts, stock and market rumors, Buffett and guru investor news, M&A and IPOs, and more.

If you have other lists of Top Picks for 2010 you would like to see in an updated version of this over the weekend and/or next week and in 2010, feel free to email it to me! Happy New Year and best wishes on your success for investing and trading in 2010!

JON C. OGG
January 1, 2010

Posted in Active Trader, Analyst Calls, Banking, Banking & Finance, Biotech, Buffett, Calendar, China, Commodities, Commodities & Metals, Corporate Governance, Dividend, Dividends & Buybacks, Editor's Picks, Entertainment, Healthcare, Housing, Insider Activity, International Markets, Large Cap Stocks, Media, Mergers & Acquisitions, Mergers and Buy Outs, Oil & Gas, Press Digest, Shareholder Issues, Technology, Technology Companies, Trading Alert, Turnarounds, Value Investing Tagged: AAPL, BIDU, C, CMCSA, CVX, DRYS, GE, HPQ, KBH, LVLT, MRVL, POT

Invitrogen’s Broader Stem Cell Monitor Kit (IVGN)

Douglas A. McIntyre — Mon, 08 Oct 2007 07:46:40 +0000

Invitrogen Corp. (NASDAQ:IVGN) has announced the launch of a new kit that allows researchers to quickly and reliably monitor the state of human embryonic stem cells. The STEMPRO® EZChek™ Multiplex PCR Kit allows scientists to monitor stem cells with one reaction, using fewer sample cells than ever before. The STEMPRO® EZChek™ Kit allows for the analysis of four early differentiation markers using a small sample and a single-tube reaction. Without the kit, researchers need to carry out five separate reactions in five tubes, using many more cells.

Invitrogen is already the leader or one of the leaders with more than $300 million per quarter in revenues in supplying tools and reagents for stem cell research with more than 1,200 products in the related market. This may be a much broader consolidated test solution, but with a portfolio that wide it may just be another day at the office.

The stock has not seen any noticeable trading pre-market. Its market cap as of Friday’s $83.90 close was $3.89 Billion, and the 52-week range is $54.70 to $84.14.

Jon C. Ogg
October 8, 2007